Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
dimanche, octobre 04
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
United Therapeutics Corp
UTHR
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$541.70
-29.68
-5.19%
Dern. MÀJ: Oct 2, 5:55 PM
$541.70
-29.68
-5.19%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
United Therapeutics Financials
United Therapeutics (UTHR) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
United Therapeutics Q2 EPS $7.27 Beats $6.88 Estimate, Sales $783.300M Miss $805.645M Estimate
Benzinga Newsdesk
Baidu, Brady And 3 Stocks To Watch Heading Into Monday
U.S. stock futures down on Monday. Focus on Baidu, Brady, United Therapeutics for earnings. XP and Ryanair to report after markets close.
Avi Kapoor
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
United Therapeutics Q1 EPS $5.82 Misses $6.92 Estimate, Sales $781.500M Miss $796.921M Estimate
United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $5.82 per share which missed the analyst consensus estimate of $6.92 by 15.9 percent. This is a 12.22 percent decrease over earnings of $6.63 per share
Benzinga Newsdesk
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings
Avi Kapoor
United Therapeutics: Q4 Earnings Insights
Benzinga Insights
